Antibiotic treatment of incipient drug-induced gingival overgrowth in adult renal transplant patients

Journal of Periodontal Research

Volumn 38, Issue 2, 2003, Pages 141-146

  Mesa, F L ^a   Osuna, A ^b   Aneiros, J ^c   Gonzalez Jaranay, M ^a   Bravo, J ^b   Junco, P ^a   Del Moral, R G ^c   O'Valle, F ^c  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Azithromycin; Cyclosporin A; Gingival overgrowth; Metronidazole

Indexed keywords

AZITHROMYCIN; CYCLOSPORIN A; METRONIDAZOLE; PLACEBO; ANTIINFECTIVE AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GINGIVA OVERGROWTH; HUMAN; KIDNEY TRANSPLANTATION; MALE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FOLLOW UP; IMAGE PROCESSING; MIDDLE AGED; NONPARAMETRIC TEST; PERIODONTICS; TOOTH PLAQUE;

ADULT; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZITHROMYCIN; CYCLOSPORINE; DENTAL PLAQUE INDEX; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GINGIVAL OVERGROWTH; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; METRONIDAZOLE; MIDDLE AGED; PERIODONTAL INDEX; PLACEBOS; REMISSION INDUCTION; STATISTICS, NONPARAMETRIC;

EID: 0038283177     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0765.2003.00383.x     Document Type: Article

References (25)

1. Daley TD, Wysocki GP. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Pathol 1986;62:417-421.
2. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: Old problem. Crit Rev Oral Biol Med 1991;2:103-107.
3. Kantarci A, Cebeci I, Tuncer O, Carin M, Firatli E. Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. J Periodontol 1999;70:587-593.
4. Wong W, Hodge MG, Lewis A, Sharpstone P, Kingswood JC. Resolution of cyclosporin-induced gingival hypertrophy with metronidazole. Lancet 1994;343:989.
5. Wahlstrom E, Zamora JU, Teichman S. Improvement in cyclosporin- associated gingival hyperplasia with azithromycin therapy. N Engl J Med 1995;332:753-754.
6. Gómez E, Sánchez-Núnez M, Sánchez JE, et al. Treatment of cyclosporin-induced gingival hyperplasia with azithromycin. Nephrol Dial Transplant 1997;12:2694-2697.
7. Palomar R, Belart M, Soy D, et al. Effectiveness and safety of azithromycin in the treatment of cyclosporine-induced gingival overgrowth. Nephron 1998; 79:101-102.
8. Jucgla A, Moreso F, Sais G, et al. The use of azithromycin for cyclosporin-induced gingival overgrowth. Br J Dermatol 1998;138:188-189.
9. Nowicki M, Kokot F, Wiecek A. Partial regression of advanced cyclosporin-induced gingival hyperplasia after treatment with azithromycin. A case report. Ann Transplant 1998;3:25-27.
10. Lesche WJ, Grossman N, Giordano J. Metronidazole in periodontitis. J Clin Periodontol 1993;20:96-104.
11. Pavicic MJ, van Winkelhoff AJ, Douque NH, Steures RW, de Graaff J. Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomicetemcomitans-associated periodontitis. J Clin Periodontol 1994;21:107-112.
12. Rotzetter PA, Le Liboux A, Pichard E, Cimasoni G. Kinetics of spiramycin/ metronidazole (Rodogyl) in human gingival crevicular fluid, saliva and blood. J Clin Periodontol 1994;21:595-600.
13. Aufricht C, Hogan EL, Ettenger RB. Oral metronidazole does not improve cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1997;11:552-555.
14. Nash MM, Zaltzman JS. Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplantation 1998;65:1611-1615.
15. Pernu HE, Pernu LM, Knuuttila ML, Huttunen KR. Gingival overgrowth among renal transplant recipients and uraemic patients. Nephrol Dial Transplant 1993;8:1254-1258.
16. O'Valle F, Mesa F, Aneiros J, et al. Gingival overgrowth induced by nifedipine and cyclosporin A. Clinical and morphometric study with image analysis. J Clin Periodontol 1995;22:591-597.
17. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000;27:217-223.
18. Mesa FL, López C, Moreno E, O'Valle F. Crecimientos gingivales inducidos por medicamentos. Periodoncia 1994;4:177-186.
19. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
20. Myrillas TT, Linden GJ, Marley JJ, Irwin CR. Cyclosporin A regulates interleukin-1 βand interleukin-6 expression in gingiva: implications for gingival overgrowth. J Periodontol 1999;70:294-300.
21. Van Oosten MAC, Notten FJW, Mikx FHM. Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose. J Dent Res 1986;65:1420-1423.
22. Amacher DE, Schomacker SJ, Retsema JA. Comparison of the effects of the new azalide antibiotic, azithromycin estolate on rat liver cytochrome P-450. Antimicrob Agents Chemother 1991;35:1186-1190.
23. Foulds G, Johnson RB. Selection of dose regimens of azithromycin. J Antimicrob Chemother 1993;31:39-50.
24. Gladue RP, Snyder ME. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 1990;34:1056-1060.
25. Ellis JS, Seymour RA, Robertson P, Butler TJ, Thomason JM. Photographic scoring of gingival overgrowth. J Clin Periodontol 2001;28:81-85.